HU9200115D0 - Materials of antitumor activity with diminished toxicity by aid of citostatic materials and xantogenates - Google Patents

Materials of antitumor activity with diminished toxicity by aid of citostatic materials and xantogenates

Info

Publication number
HU9200115D0
HU9200115D0 HU92115A HU11592A HU9200115D0 HU 9200115 D0 HU9200115 D0 HU 9200115D0 HU 92115 A HU92115 A HU 92115A HU 11592 A HU11592 A HU 11592A HU 9200115 D0 HU9200115 D0 HU 9200115D0
Authority
HU
Hungary
Prior art keywords
materials
xantogenates
citostatic
aid
antitumor activity
Prior art date
Application number
HU92115A
Other languages
Hungarian (hu)
Other versions
HUT62787A (en
Inventor
Gerhard Sauer
Eberhard Mann
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of HU9200115D0 publication Critical patent/HU9200115D0/en
Publication of HUT62787A publication Critical patent/HUT62787A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/191Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU92115A 1990-05-15 1991-05-14 Process for producing antitumoral pharmaceutical composition comprising a reduced toxicity cytostatic agent and a xanthogenate HUT62787A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4015603 1990-05-15
DE4115559A DE4115559A1 (en) 1990-05-15 1991-05-13 ANTITUARY AGENTS WITH REDUCED TOXICITY BASED ON CYTOSTATICS AND XANTHOGENATES

Publications (2)

Publication Number Publication Date
HU9200115D0 true HU9200115D0 (en) 1992-06-29
HUT62787A HUT62787A (en) 1993-06-28

Family

ID=25893234

Family Applications (1)

Application Number Title Priority Date Filing Date
HU92115A HUT62787A (en) 1990-05-15 1991-05-14 Process for producing antitumoral pharmaceutical composition comprising a reduced toxicity cytostatic agent and a xanthogenate

Country Status (8)

Country Link
EP (1) EP0482172A1 (en)
JP (1) JPH05500067A (en)
AU (1) AU7870791A (en)
CA (1) CA2064067A1 (en)
DE (1) DE4115559A1 (en)
HU (1) HUT62787A (en)
IE (1) IE911650A1 (en)
WO (1) WO1991017757A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4415263C1 (en) * 1994-04-15 1995-11-30 Asta Medica Ag Cis- [trans-1,2-cyclobutane bis (methylamine) -N, N '] - [(2S) -lactato-O · 1 ·, O · 2 ·] -platinum (II) trihydrate (lobaplatin trihydrate), its manufacture and medicinal use
EP1391221A1 (en) * 2002-08-23 2004-02-25 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease
DE10343365A1 (en) * 2003-09-17 2005-04-14 Biosphings Ag Pharmaceutical Formulations of Xanthogenates and Inhibitors of Viral Nucleic Acid Replication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625948A1 (en) * 1985-08-02 1987-02-19 Merz & Co Gmbh & Co Synergistic antiviral and antitumour compsns. - contg. cpd. with antiviral and antitumour activity, pref. xanthate, and cpd. contg. both hydrophilic and lipophilic gps., e.g. decanoic acid

Also Published As

Publication number Publication date
HUT62787A (en) 1993-06-28
WO1991017757A1 (en) 1991-11-28
DE4115559A1 (en) 1991-11-21
CA2064067A1 (en) 1991-11-16
EP0482172A1 (en) 1992-04-29
AU7870791A (en) 1991-12-10
JPH05500067A (en) 1993-01-14
IE911650A1 (en) 1991-11-20

Similar Documents

Publication Publication Date Title
GB2248215B (en) Movement of aircraft
GB2245149B (en) Diaper of pants type
AU8328691A (en) Isocarbostiryl compounds and antitumor use thereof
IL71908A0 (en) Drug preparations of reduced toxicity
NZ247205A (en) Intermediate compounds: 4-ethyl-5-fluoropyrimidine and 4-chloro-6-ethyl-5-fluoropyrimidine
EP0482649A3 (en) Cm-chitin derivatives and use thereof
EP0468927A3 (en) Derivatives of carboxymethylcyclopropane
ZA912630B (en) New ethylene-substituted phenylalkylethylenediamine-platinum(ii or iv)derivatives and phenylalkylethylenediamines
HU9200115D0 (en) Materials of antitumor activity with diminished toxicity by aid of citostatic materials and xantogenates
NZ238428A (en) Cephalosporin derivatives and medicaments
GB9213531D0 (en) Structure of assembly line
AU7954691A (en) Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
EP0663816A4 (en) Novel class of phosphocholine derivatives having antifungal activity.
GB9006371D0 (en) Active control of noise
IL99212A0 (en) Cyclohexenol derivatives and their preparation
GB9017964D0 (en) Destruction of microorganisms
ZA935486B (en) Pyridoindolobenzodiazepines and derivatives as anti-psychotics
ZA913651B (en) Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates
GB2248013B (en) Support arrangement and assembly
EP0483615A3 (en) 1-halogen-1-azolylmethan derivatives and fungicides containing them
GB9100562D0 (en) Structure of ash-tray assembly
GB9025377D0 (en) Compounds having antiviral and cytotoxic activity
GB9017996D0 (en) Compounds having antitumoral and/or antiviral activity
IE901861L (en) Pyrimidine derivatives and intermediates thereof
CS15990A2 (en) Derivatives of 1-phenyl-5-mercaptotetrazol